Sun Pharmaceuticals Industries Ltd, the largest drug maker in India, may move on Wednesday after it announced of entering into a definitive agreements to acquire 85.1% stake in JSC Biosintez, a Russian Pharmaceutical company at $24 million.
The acquisition will be executed through subsidiary companies, Sun Pharma said Wednesday in a statement to the stock exchanges.
The company would also assume a debt of nearly $36 million for this acquisition.
On Tuesday, Sun Pharmaceuticals Industries fell 0.17% to Rs 689.20 at the close of Stock trading on the National Stock Exchange.
Free Trial On Stock, Commodity & Forex Trading Tips @ http://bit.ly/1T3cqCb
The acquisition will be executed through subsidiary companies, Sun Pharma said Wednesday in a statement to the stock exchanges.
The company would also assume a debt of nearly $36 million for this acquisition.
On Tuesday, Sun Pharmaceuticals Industries fell 0.17% to Rs 689.20 at the close of Stock trading on the National Stock Exchange.
Free Trial On Stock, Commodity & Forex Trading Tips @ http://bit.ly/1T3cqCb
No comments:
Post a Comment